Match Document Document Title
11069056 Multi-modal computer-aided diagnosis systems and methods for prostate cancer  
Methods and apparatus for computer-aided prostate condition diagnosis are disclosed. An example computer-aided prostate condition diagnosis apparatus includes a memory to store instructions and a...
11067585 Method for monitoring cancer and/or inflammatory reaction based on RelB phosphorylation  
The present Inventors demonstrated that the RelB subunit of NFκB plays a crucial role in promoting cell migration. More precisely, they identified that this pro-migratory activity is mediated by...
11066710 Method for detecting an increased risk or incidence of colorectal cancer  
The present invention relates to the methods and products for detection of colorectal cancer. Additionally, the present invention relates to methods and products for determining the probability,...
11066709 Methods for diagnosing and treating cancer by means of the expression status and mutational status of NRF2 and downstream target genes of said gene  
The invention provides methods of identifying a subject having cancer, such as lung cancer, by analyzing expression levels of one or more NRF2 splice variants or NRF2 target genes. The invention...
11066708 Compositions and methods for screening and diagnosis of prostate cancer  
The present invention provides methods of screening for and diagnosing prostate cancer and methods of choosing a therapeutic for prostate cancer based on using KDM5D expression level to identify...
11066644 Method of producing natural killer cells and composition for treating cancer  
A method for producing natural killer cells is disclosed. The method comprises isolating peripheral blood mononuclear cells (PBMCs) from a blood sample; isolating at least one of CD56+ cells...
11066478 Intravesical therapy for bladder cancer  
This invention relates to an intravesical therapy for bladder cancer.
11066421 Synthetic cinchona alkaloids against cancer  
Novel cinchona alkaloid compounds have been synthesized and discovered to have potent cytotoxic activity against cancer cells both in vitro and in vivo. Cinchona alkaloids, including trimeric...
11066412 Substituted pyrrolo[2,1-a]phthalazines and benzo[g]pyrrolo[2,1-a]phthalazines for the treatment of cancer  
Disclosed herein are novel bifunctional compounds and their uses for the treatment and/or prophylaxis of cancers. The bifunctional compound disclosed herein has the structure of formula (I),...
11066405 Bicyclic compounds and their use in the treatment of cancer  
The present disclosure is directed to novel compounds of Formula I and pharmaceutically acceptable salts, solvates, solvates of the salt and prodrugs thereof, useful in the prevention (e.g.,...
11066400 Compounds for the treatment of cancer  
The present invention relates to a FoxM1 gene splicing modifier selected from a compound of formula (I) or of formula (VI) wherein A and B are as defined herein, or a pharmaceutically acceptable...
11066370 Kinase inhibitor compounds, compositions, and methods of treating cancer  
The present invention relates to a compound having the structure of formula (I) or a stereoisomer, pharmaceutically acceptable salt, oxide, or solvate thereof, where X, Y, Z, R, R1, R2, R3, R4,...
11065471 Systems and methods for automatic, customized radiation treatment plan generation for cancer  
Systems and methods for automatic, customized radiation treatment plan generation for cancer are disclosed. According to an aspect, a method includes receiving data indicating anatomy information...
11065470 Tissue sampling and catheter selection cancer treatment methods  
A catheter treatment apparatus comprises an elongate tubular member and an expandable support. The expandable support comprises a radioactive substance to treat cancerous tissue and is configured...
11065341 DE-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy  
The present invention generally provides compositions methods and composition relating to the diagnosis and/or treatment of cancers having a cell surface de-N-acetylated sialic acid antigen, e.g.,...
11065331 Immune adjuvant for cancer  
The present invention relates to a medicament for treating cancer or infectious disease, the medicament comprising an immune checkpoint blockade and an adjuvant composition. More specifically, the...
11065315 Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers  
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The...
11065314 Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers  
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The...
11065293 Pharmaceutical composition for decreasing the side effects of cancer drug, and manufacturing method and uses thereof  
The present invention provides a pharmaceutical composition comprising a mushroom, a rhizome, a fruit, a leaf, a flower, an alga, an energy-rich liquid, a salt-rich liquid, an assist agent and an...
11065269 Method of using astaxanthin for the treatment of diseases, and more particularly, the treatment of cancer  
A method of treating a subject afflicted with cancer, arthritis, diabetes, lupus, fibromyalgia or dementia includes administering a therapeutic amount of a glucosidic astaxanthin to the subject in...
11065245 Priming of cancer cells with low dose naltrexone  
The disclosure provides methods of treating a tumor/cancer by administering naltrexone or an analogue thereof, followed by a recovery phase, and then administering a small molecule signaling...
11065221 Buthionine sulfoximine and a metallodrug for the treatment of cancer, HIV or a rheumatic disease  
There is disclosed buthionine sulfoximine (BSO) for use in a method of treatment of cancer, HIV or a rheumatic disease. The method comprises administering (a) BSO at a dosage of less than or equal...
11064887 Interactive electronic treatment assistance for benign prostatic hyperplasia and advanced prostate cancer  
Computer-implemented methods for providing interactive electronic treatment assistance for benign prostatic hyperplasia and advanced prostate cancer are disclosed. The methods can include...
11061034 Blood biomarker for use in evaluation of effect of drug therapy on kidney cancer  
Disclosed are methods for determining the efficacy of a pharmacotherapy drug for kidney cancer using a blood test. The methods include the evaluation of the effect of a drug therapy for the...
11061033 Assay for detection of bladder or prostate cancer  
A Fe(II)- and Ca+2-chelated alginate/gelatin conjugate.
11061029 Methods of determining colorectal cancer status in an individual  
A method of determining colorectal cancer status in an individual, which comprises abundance profiling of the individual's microbiome.
11061027 Materials and methods for evaluating and treating cancer  
This document provides methods and materials for detecting PCA-2-specific autoantibodies, which can be associated with paraneoplastic neurological disorders and cancers associated with...
11060152 Methods for the surveillance, diagnosis and screening of bladder cancer  
A method of diagnosing or predicting a bladder cancer, or a risk of a developing a bladder cancer in a subject is provided, which method includes the detection of specific mutations in the FGFR3...
11060151 Methods and materials for staging and treating skin cancer  
This document provides methods and materials for staging and treating skin cancer (e.g., metastatic malignant pigmented skin lesions). For example, methods and materials for using an ITLP...
11060150 Methods and materials for assessing and treating cancer  
This document provides methods and materials involved in assessing cancer (e.g., breast cancer). For example, methods and materials for determining whether or not a cancer patient (e.g., a breast...
11060148 Diagnosing and treating colorectal cancer  
Methods for predicting risk of developing colorectal cancer, for treating colorectal cancer, and reducing risk of developing colorectal cancer.
11058754 Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers  
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The...
11058753 Cancer vaccines  
The present disclosure provides (i) isolated immunogenic TAA polypeptides (i.e., an immunogenic MUC1 polypeptides, an immunogenic MSLN polypeptides, and an immunogenic TERT polypeptides), (ii)...
11058744 Composition for treating prostate cancer  
The present invention relates to a composition for treating prostate cancer and, more specifically, to a composition for treating prostate cancer, which contains a peptide derived from telomerase...
11058709 Methods of treating breast cancer  
Provided herein are methods, compounds, and compositions for reducing expression of a MaTAR in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or...
11058702 Methods and compositions for the treatment of cancer with 5-iodo-2-pyrimidinone-2′-deoxyribose (IPdR)  
Provided are methods of treating a human patient having cancer by administering IPdR to the patient in the form of an oral drug and administering radiation therapy (RT) to the patient. The method...
11058701 Cytarabine conjugates for cancer therapy  
Provided relates to conjugates including cytarabine and an amino acid for use in the treatment of cancer. Further, the subject matter relates to conjugates of cytarabine and aspartic acid for use...
11058687 Human papilloma virus as predictor of cancer prognosis  
Methods of treating a head and neck cancer are disclosed.
11058663 Lipidic furan, pyrrole, and thiophene compounds for treatment of cancer, neurological disorders, and fibrotic disorders  
Compounds, methods, and compositions are provided for the treatment of cancer, neurological disorders, and fibrotic disorders. Specifically, the invention includes administering an effective...
11058657 Nutritional composition for use in therapy of cancer patients  
The invention relates to PUFA, vitamin E, vitamin D and the protein bound amino acids glycine, arginine and tryptophan as active ingredients for use in therapy of cancer patients, wherein an...
11058639 Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer  
Disclosed are combination therapy methods useful for the therapeutic treatment of cancer by combining local administration of compositions containing antineoplastic particles, such as taxane...
11056236 Methods for using artificial neural network analysis on flow cytometry data for cancer diagnosis  
The present disclosure provides methods for applying artificial neural networks to flow cytometry data generated from biological samples to diagnose and characterize cancer in a subject.
11055844 Predicting response to immunotherapy using computer extracted features of cancer nuclei from hematoxylin and eosin (HandE) stained images of non-small cell lung cancer (NSCLC)  
Embodiments access a digitized image of tissue demonstrating non-small cell lung cancer (NSCLC), the tissue including a plurality of cellular nuclei; segment the plurality of cellular nuclei...
11053553 Detection of CLDN18-ARHGAP6 fusion gene or CLDN18-ARHGAP26 fusion gene in pancreatic cancer  
The purpose is to reveal a polynucleotide that is a novel causal gene of pancreatic cancer and thereby provide a method for detecting the polynucleotide or a polypeptide encoded thereby to select...
11053551 Method and apparatus for determining a probability of colorectal cancer in a subject  
A method of determining a probability that a human test subject has colorectal cancer as opposed to not having colorectal cancer is disclosed. The method comprises, for each gene of a set of one...
11053542 Compositions and methods for screening mutations in thyroid cancer  
The present technology relates to methods for determining whether a patient having thyroid nodules with indeterminate cytology will benefit from diagnostic surgery, e.g., lobectomy. These methods...
11053476 Generation of cancer stem cells and use thereof  
Methods, kits and compositions for generating cancer stem cells are provided.
11053314 Methods to eliminate cancer stem cells by targeting CD47  
Described herein is the discovery that cancer stem cells (CSCs) can be induced to differentiate by altering CD47 signaling. Provided herein are methods and compositions for inducing...
11053296 Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers  
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The...
11053254 Crystalline forms of mitomycin C for treatment of cancer  
Synthesis and characterization of novel crystalline mitomycin C forms suitable for pharmaceutical compositions in drug delivery systems to treat human or warm-blooded diseases.